Temporal Changes of Diagnostic Accuracy for Multiple System Atrophy: A 15-year Analysis from 2008 to 2022

A Phase 2 Study of ATH434, a Novel Inhibitor of a-synuclein Aggregation, for the Treatment of Multiple System Atrophy (MSA)